Introduction
The antibiotics have facilitated the successful treatment of bacterial infections and the performance of intrusive medical procedures, including chemotherapy and surgery. However, many bacterial strains have evolved to become resistant to the antibiotics by mutating their genes or by importing new genes from other strains. Thus, the discovery and development of new antibiotics has become scientifically more complicated, more time consuming, and more expensive. Consequently, the rate of antibiotics development to fight these strains has constantly slowed down. In fact, for more than 30 years until the recent release of the new class of antibiotics like streptogramins, Synercid, no new antibiotic chemical structures have entered the market [1] . Thus, we have to find a new class of antimicrobial agents as alternatives to these traditional antibiotics. Besides this, antibiotics have been used in food animals from the time of their discovery and development, and have been used extensively in farms as therapeutic remedies or growth promoters [2] . These days, however, an analysis of 30 antibiotics used in animal feed has found that the majority of them were supposed to be contributing to the resistance problem in bacterial infections. Widespread use of antibiotics induces microbial resistance, which renders the antibiotics ineffective against serious and life-threatening infections disease and makes it difficult or impossible to treat infections with ordinary antibiotics. Furthermore, the US Food and Drug Administration is cracking down on antibiotics in farming, and they announced new policies to reduce the widespread use of antibiotics in farm animals [3] . In recent years, despite the several precautionary measures to avoid development of resistance to antibiotics, new antibiotics are urgently needed to overcome this problem [4] . One approach to this problem of resistance to current antibiotics is to look to ancient evolutionary weapons. All organisms possess a variety of broad-spectrum antimicrobial peptides (AMPs) known as cationic peptides.
Cationic amphipathic AMPs are found in every complex natural species [1, [5] [6] [7] [8] . These peptides are important regulators of the hosts' innate immune responses to microorganisms [9, 10] . In the 1980s, peptides isolated from frogs' skin and insects' lymph were found to show antibacterial activity. Since these early findings, various cationic AMPs have been reported in all species. Currently, more than 1,200 different AMPs have been identified, isolated, and purified from various organisms [1, [10] [11] [12] . Common features maintained among these cationic AMPs are their ability to fold into amphipathic conformations, their cationic charge interacts with the anionic charge on Fig. 1 . Helical wheel patterns of the designed lactophoricin (LPcin) analog peptides, which have fewer amino acids and better amphipathic potential for cationic peptides in Table 1 .
These modified LPcin peptides had their C-terminal shortened by serial elimination of two amino acids. The mutated analogs were designed to improve their hydrophobic and amphipathic characteristics by mutating amino acids.
the bacterial membrane, and their amphiphilic nature allows them to penetrate through membranes better than other peptides [13] [14] [15] [16] [17] . Concurrent with their direct antimicrobial activities against bacteria, these peptides play an extra important role as antibiotic substitutes for fungi [18] and protozoa [19] . Lactophoricin (LPcin) is separated from bovine milk and is a good candidate for a cationic amphipathic AMP, consisting of 23 amino acids [20] [21] [22] . The N-terminal 6 amino acids truncated variant of LPcin has been confirmed in previous experiments to have no antibiotic activity [23] . In this paper, the 11 peptide analogs in Table 1 and Fig. 1 were engineered with shorter amino acids, greater cationic charge, and clearly divided hydrophilic and hydrophobic sections by looking at their helical secondary structure in a membrane environment using a helical wheel [24, 25] . Analogs were made with mutated amino acid sequences and/or amino acids cut from the original sequence to shorten the peptides and improve their activity [5, 10, 16, 22] . The analogs were synthesized using Fmoc (9-fluorenylmethoxycarbonyl) with modifications of N-terminal acetylation and C-terminal amidation. The inhibition zone and minimum inhibitory concentration (MIC) of LPcin analogs against five pathogenic microorganisms were carried out to determine their antimicrobial activity. Among them, three of the most consistently effective analogs, LP1-C8(LPcin-YK1), LP1-T2KT6W(LPcin-YK2), and LP1-T2KT6W-C8(LPcin-YK3), were chosen for further in vitro activity analysis. Tellingly, these peptides appear to interact with the membrane and exert better activities than does LPcin. In the present work, we provide a potential substitute for currently used antimicrobial agents: novel AMPs, LPcin analogs derived from an abundant and natural source of bovine milk. Furthermore, we confirm the potential application of these peptides as alternative antimicrobial agents against bacteria and fungi.
Materials and Methods

Design of Various LPcin Analogs with Enhanced Activities
A previous study found that the N-terminus of LPcin was more important than the C-terminus for antimicrobial activities [23] . Therefore, C-terminal truncated variants of LPcin (LP1-C2, LP1-C4, LP1-C6, LP1-C8, LP1-C10) were synthesized. These modified LPcin peptides were shortened by serial elimination of two amino acids. The mutated analogs of LPcin (LP1-T6W, LP1-T2W, LP1-T2K&T6W, LP1-T2K, LP1-T2K&T6W) were also synthesized. For N-terminal residues, threonine of the second amino acid and/or sixth amino acid for LPcin were mutated to lysine and/or tryptophan to improve the hydrophobic and amphipathic characteristics for cationic peptides [26, 27] . Both C-terminal truncated and mutated analogs of LPcin were also synthesized. Fig. 1 and Table 1 show that the designed LPcin analog peptides are shorter in length and better amphipathic properties for cationic peptides. All the designed analog peptides were synthesized by Peptron (95% purity; Korea).
Preparation of Bacterial Culture and Inoculums
Gram-positive (Listeria innocua MC2 KCTC 3658 and Staphylococcus aureus ATCC 6538) and gram-negative (Pseudomonas aeruginosa ATCC 27853, Salmonella typhimurium ATCC 19430, and Escherichia coli KCTC 1682) species were used for the antimicrobial assays. For the antibacterial activity assay, fresh colonies of each strain cultured on 3.7% BHI (Bacto brain heart infusion; Beckton Dickinson and Company, USA) agar plates were used to inoculate 3.7% BHI medium and grown overnight at 37°C. The culture was transferred to a new tube with fresh 3.7% BHI medium and incubated for another 2 h on a shaker. Then, the microorganisms were harvested by centrifugation at 16,370 ×g and resuspended in 0.037% BHI broth used for the assay. This log-phase inoculum was resuspended to reach an appropriate OD 
Disc Agar Diffusion Assay
The antimicrobial activity of LPcin analogs was assessed by disc agar diffusion tests using 3.7% BHI agar plate. The activity was estimated by measuring the diffusion regions of inhibition (data not shown). Five pathogen microorganisms were tested for activity: both gram-positive (L. innocua MC2 KCTC 3658 and S. aureus ATCC 6538) and gram-negative (P. aeruginosa ATCC 27853, S. typhimurium ATCC 19430, and E. coli KCTC 1682) species. The 3.7% BHI agar medium plate was swabbed with a bacterial suspension (10 8 CFU/ml) and kept for 30 min at 37°C. Filter paper discs (Whatman No. 1, UK) of 6 mm diameter were prepared and sterilized in an autoclave. The filter paper discs were soaked with 20 µl of each analog peptide solution and placed on the surface of the inoculated 3.7% BHI agar plates and grown in a 37°C oven for 24 h. Three independent experiments were carried out, and the final diameters were obtained as an average value. From these tests, three analog peptides with enhanced antimicrobial activity were chosen: LP1-C8, LP1-T2KT6W, and LP1-T2KT6W-C8, each named LPcin-YK1, LPcin-YK2, LPcin-YK3.
Minimal Inhibitory Concentration Determination
The MIC was determined by a broth macrodilution method using sterile 96-well microtiter plates (SPL Life Science). Serial 2-fold dilutions (1.8-900 µM) of each peptide were prepared in 0.037% BHI medium at a volume of 100 µl per well. The peptide solutions were mixed with 5 µl of bacterial suspension in a 96-well plate and incubated at 37°C overnight. MIC is defined as the lowest concentration of the peptide in the absence of visible growth of the bacteria. 
Cytotoxicity Assay
We used the Wst-8 (water-soluble tetrazolium) assay of Cyto X (Cell viability assay kit; LPS Solution, Korea) on the five mammalian cell lines to test the effect of LPcin-YK3 peptide on cell metabolism. The mammalian cells VERO, HFL-1, L929, NIH 3T3, and CHO-K1 were used.
Effect of Divalent Metal Cation
The activity of the AMPs is affected by the presence of divalent cations [28] . The disc diffusion method was used to measure the effect of divalent cations. The divalent cations Cu (Yakuri Pure Chemicals Co. Ltd, Japan) were soaked to filter paper discs that were placed on the surface of the inoculated BHI agar plates to final concentrations of 12.5, 25, 50, and 100 mM as a control. Both metal ions (100 mM) were incubated with the three analog peptides at a concentration of 500 µM in BHI agar plates for 24 h at 37°C.
Circular Dichroism (CD) Spectroscopy
The secondary structures and conformational propensities of the analog peptides were measured with a J710 spectropolarimeter (Jasco, USA) following the procedure of a previous study [29] .
Briefly, the CD results were obtained using a 1-mm-pathlength cylindrical cuvette cell at a wavelength of 190 to 260 nm, averaged over 5 scan values, and measured with a step resolution of 0.2 nm and a sensitivity of 20 mdeg. The CD spectra of the three analog peptides were obtained in water and membrane environments. First, the spectra of the peptides in the water environment at ambient temperature were measured and then in the presence of dodecylphosphocholine (DPC) at concentrations between 20 and 100 mm. The average blank spectra were subtracted from the data of the peptide spectra.
Results
The 11 different LPcin analog peptides were assessed by disc agar diffusion tests using five microorganisms. The resulting agar diffusion size indicated that the peptides inhibited the growth and development of the bacteria. Their diameters were used to indicate each peptide's antibacterial activity (data not shown). Of the 11 tested analogs, LP1-C8 (LPcin-YK1), LP1-T2KT6W (LPcin-YK2), and LP1-T2KT6W-C8 (LPcin-YK3) showed the best antibacterial activity and were selected for subsequent analysis.
Each sample was characterized by disc agar diffusion tests and their antimicrobial properties were assessed, as shown in Figs. 2 and 3 . The wider inhibitory zones (i.e., the agar holes) shown by LPcin-YK3 demonstrated its superior microbial activity over LPcin-1 against both gram-positive and gram-negative bacteria. Interestingly, LPcin-YK1 has been shown to be more effective against gram-negative bacteria, especially S. aureus and E. coli, than against grampositive bacteria. In Fig. 3 and Table 2 , microbroth dilution tests using the expressed LPcin and three LPcin analog peptides were conducted in BHI media using the five pathogens, as mentioned above. Data indicated that the The antimicrobial activities of the three analog peptides were tested using BHI agar plates spread with five pathogens. The three analog peptides showed better antimicrobial activity against the five pathogens than did LPcin.
three analog peptides exhibited better antibacterial activities than did LPcin. In the case of LPcin-YK3, <20 μM of peptide was sufficient to prevent significant pathogen growth, except of E. coli. In most cases, the use of a higher concentration of peptide gave sufficient activity to suppress both gram-negative and gram-positive bacteria.
We also assessed the cytotoxic activity of LPcin-YK3 peptide in normal mammalian cell lines, and IC values of the peptide are shown at Table 3 . The cell lines NIH 3T3 and CHO-K1 were more sensitive to LPcin-YK3 peptide than VERO, HFL-1, and L929. These results indicated that LPcin-YK3 peptide could not induce significant cell killing of normal cells.
AMPs are already known to have antimicrobial activities against various bacteria, and their activity is known to be affected by the presence of divalent metal cations [28] . Divalent cations, such as cupric, zinc, and magnesium ions, are cations that bind with the negatively charged bacteria membrane. Thus, increasing concentrations of divalent metal ions affect the interaction between AMPs and bacteria. As shown in Table 4 summarizing the effect of divalent metal cations, there was a considerable inhibition zone when only cupric and zinc ions are present, which increased with increasing metal ion concentration. The results of the tests developed with analog peptides suggested that antimicrobial activity can be increased by adding divalent metal cations.
Additionally, a propidium iodide (PI) staining assay was also used against Candida albicans (KCTC 7270) to determine the extent of cell viability that is peptide-induced membrane permeabilization (data not shown). When the cell membrane is perturbed by the peptide, the fluorescent dye enters the cells and binds with the DNA, resulting in fluorescence [30] . C. albicans cells were treated with LPcin-YK3 peptide and amphotericin B, an antifungal drug. The high contrast PI staining in C. albicans was evidence of dead cells present on the surface of the peptide-immobilized catheters.
Because CD is highly dependent on the secondary structure of proteins and peptides, it is possible to monitor the structural changes of the peptides under various conditions, such as temperature, mutations, denaturants, or binding interactions, and to measure the secondary structure [31] . The CD spectra of the three analog peptides are shown in Fig. 4 . In aqueous solutions, the secondary structure of all the peptides showed random coils but the spectra indicated clear α-helical-rich conformations in DPC micelle solutions, with dichroic minimal values at 210 and 225 nm and a maximum near 195 nm. These results show that the peptides have a well-defined stable, amphipathic α-helix that is strongly correlated with antimicrobial activity in the presence of lipids. Furthermore, the three selected peptides with enhanced antimicrobial activities were then expressed using recombinant DNA technology in E. coli and purified by several biological techniques and subjected to further three dimensional structural analyses to determine their antibacterial mechanisms.
Discussion
The serious public health problem of increasing resistance to antibacterial agents has led to the urgent need to discover novel classes of antibiotics. Cationic AMPs that are found in virtually all organisms are being considered as nextgeneration antibiotics and naturally occurring components of the innate immunity. The advantage of AMPs, a solution to the growing resistance problems of conventional antibiotics, has triggered attempts to develop AMPs as drugs, therapeutic agents, and growth promotants [32, 33] .
We designed a novel AMP on the basis of LPcin, isolated from bovine milk, and successfully confirmed its activity against both gram-positive and gram-negative bacteria and even fungi. Eleven different variants of AMP LPcin were designed, synthesized, and tested for enhanced antibacterial activities. In many studies, it has already been possible to simplify synthesis by reducing the length of the peptide while maintaining the antimicrobial activity of AMPs [34] . Thus, C-terminal truncated variants of LPcin analogs were designed and tested for their antimicrobial activity. The results revealed that only LPcin-C8 showed antimicrobial In the presence of DPC micelles, the CD spectra changed obviously to two negative maxima of molar ellipticity at 210 and 225 nm. These studies reveal that the three analog peptides have unstructured random coil conformation in aqueous solution, but form a high percentage of α-helical secondary structures in the presence of detergent micelle, which is similar to membrane environments. activity and that LPcin-C10 did not show any antimicrobial activity. These results led us to focus on the N-terminal 15 residues preceding His16 as the minimal requirement for the activity. Furthermore, reconstituting the hydrophobic sector by replacing the second threonine residue with tryptophan and improving the amphipathicity by replacing the sixth threonine residue with lysine dramatically improved the potency. We demonstrated that three selected analog peptides, LPcin-YK1 (LP1-C8), LPcin-YK2 (LP1-T2KT6W), and LPcin-YK3 (LP1-T2KT6W-C8), have a broad spectrum of antimicrobial effect stronger than that of the original LPcin sequence and showed potential as novel AMPs. A cytotoxicity assay in various mammalian cell lines showed no cytotoxicity resulted from our antimicrobial peptides. In addition, the effect of divalent metal ions on the antimicrobial activity of the three analog peptides was examined. We observed that Cu resulted in a significant increase in antimicrobial activity of the analog peptides on both gram-positive and gram-negative bacteria. Moreover, in our other study, their tertiary structures were confirmed by liquid/solid-state NMR spectroscopy, and molecular dynamics simulation [35] . The present study demonstrated the broad microbicidal effectiveness of LPcin-YK3 against microorganisms appearing in topical infections, including gram-positive and gram-negative bacteria and fungi, and supported its potential as a promising agent in the treatment of infections. These results will be useful for designing peptides with enhanced antimicrobial activity and facilitating the development of novel antibiotics based on their structure and perturbation mechanism of membrane.
